We are live on ! Find out more
NI

Nepsis Inc Portfolio holdings

AUM $295M
1-Year Est. Return 35.44%
This Fund
S&P 500
This Quarter Est. Return
+14.08%
1 Year Est. Return
+35.44%
3 Year Est. Return
+115.51%
5 Year Est. Return
+196.69%
10 Year Est. Return
+848.99%
AUM
$299M
AUM Growth
+$22M
Cap. Flow
-$6.06M
Cap. Flow %
-2.03%
Top 10 Hldgs %
55.32%
Holding
32
New
2
Increased
17
Reduced
11
Closed
2

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$12.1M
2
EG icon
Everest Group
EG
+$6.53M
3
PETQ
PetIQ, Inc. Class A Common Stock
PETQ
+$3.8M
4
HCAT icon
Health Catalyst
HCAT
+$1.5M
5
FANG icon
Diamondback Energy
FANG
+$1.19M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$14.9M
2
FUBO icon
FuboTV Inc
FUBO
+$5.58M
3
FFIV icon
F5
FFIV
+$4.46M
4
VZ icon
Verizon
VZ
+$3.41M
5
PXD
Pioneer Natural Resource Co.
PXD
+$3.19M

Sector Composition

Rank Sector Weight
1 Financials 29.94%
2 Healthcare 25.29%
3 Technology 23.65%
4 Energy 15.38%
5 Real Estate 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVN icon
1
Devon Energy
DVN
$52.1B
$25M 8.39%
407,132
-889
-0.2% -$60.6K
RNR icon
2
RenaissanceRe
RNR
$13.3B
$21.5M 7.2%
116,764
+952
+0.8% +$160K
AIG icon
3
American International
AIG
$41.7B
$19.2M 6.44%
304,049
+7,308
+2% +$425K
CB icon
4
Chubb
CB
$135B
$15.8M 5.28%
71,494
+253
+0.4% +$52.6K
CI icon
5
Cigna
CI
$73.8B
$15.3M 5.13%
46,216
+56
+0.1% +$17.7K
JNJ icon
6
Johnson & Johnson
JNJ
$618B
$15.2M 5.09%
86,137
-405
-0.5% -$69.9K
QCOM icon
7
Qualcomm
QCOM
$155B
$13.7M 4.6%
124,967
+2,181
+2% +$255K
BMY icon
8
Bristol-Myers Squibb
BMY
$133B
$13.2M 4.44%
184,122
+4,943
+3% +$373K
JAZZ icon
9
Jazz Pharmaceuticals
JAZZ
$15.9B
$13.2M 4.41%
+82,606
New +$12.1M
MA icon
10
Mastercard
MA
$506B
$13M 4.35%
37,393
+37
+0.1% +$12.2K
V icon
11
Visa
V
$684B
$13M 4.34%
62,335
+101
+0.2% +$20.4K
SHOP icon
12
Shopify
SHOP
$152B
$12.7M 4.25%
365,564
+23,671
+7% +$808K
FANG icon
13
Diamondback Energy
FANG
$57.1B
$12.6M 4.2%
91,794
+8,122
+10% +$1.19M
XYZ
14
Block Inc
XYZ
$48.4B
$12M 4.01%
190,526
+4,963
+3% +$306K
HCAT icon
15
Health Catalyst
HCAT
$154M
$10.4M 3.5%
982,281
+155,440
+19% +$1.5M
AMD icon
16
Advanced Micro Devices
AMD
$776B
$9.98M 3.34%
154,109
+8,810
+6% +$582K
CYBR
17
DELISTED
CyberArk
CYBR
$8.69M 2.91%
67,001
-859
-1% -$124K
PXD
18
DELISTED
Pioneer Natural Resource Co.
PXD
$8.34M 2.79%
36,512
-13,123
-26% -$3.19M
PETQ
19
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$8.16M 2.73%
885,197
+406,825
+85% +$3.8M
EG icon
20
Everest Group
EG
$14.5B
$6.94M 2.32%
+20,960
New +$6.53M
FFIV icon
21
F5
FFIV
$22.9B
$6.64M 2.22%
46,271
-30,435
-40% -$4.46M
FSLR icon
22
First Solar
FSLR
$22.7B
$6.27M 2.1%
41,871
-14,824
-26% -$2.2M
GIS icon
23
General Mills
GIS
$19.1B
$5.47M 1.83%
65,289
-3,934
-6% -$320K
IRM icon
24
Iron Mountain
IRM
$36.4B
$3.25M 1.09%
65,258
+741
+1% +$37.4K
NHI icon
25
National Health Investors
NHI
$3.72B
$2.71M 0.91%
51,908
+2,098
+4% +$115K
1
2

Similar funds

CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
PC
Permit Capital West Conshohocken, Pennsylvania $294M AUM 27.9% 1-Year Est. Return
SM
Selkirk Management Chatham, New Jersey $294M AUM 26.84% 1-Year Est. Return
BIC
B&I Capital Zurich, Switzerland $294M AUM 3.09% 1-Year Est. Return
TJHA
Thomas J. Herzfeld Advisors Miami Beach, Florida $294M AUM 2.62% 1-Year Est. Return
FRA
Front Row Advisors Tiburon, California $296M AUM 34.73% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Nepsis Inc's Q4 2022 Portfolio in Review

As of Q4 2022, Nepsis Inc held 32 positions worth $299M, up 7.9% from $277M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Nepsis Inc's Q4 2022 filing shows 2 new, 17 increased, 11 reduced and 2 closed positions. Its largest new stake was Jazz Pharmaceuticals: 82,606 shares worth $13.2M. The largest sale was CVS Health, an estimated $14.9M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

  • Nepsis Inc's largest Q4 2022 buy was Jazz Pharmaceuticals: 82,606 shares worth $13.2M.
  • Nepsis Inc added most to PetIQ, Inc. Class A Common Stock in Q4 2022, an estimated $3.8M increase.
  • Nepsis Inc's biggest Q4 2022 reduction was F5, cutting an estimated $4.46M.
  • Nepsis Inc fully exited CVS Health in Q4 2022, selling an estimated $14.9M.
  • Nepsis Inc's ten largest holdings make up 55% of its $299M portfolio in Q4 2022.
  • Nepsis Inc opened 2 new positions and closed 2 in Q4 2022.
  • Nepsis Inc's portfolio value rose 7.9% quarter-over-quarter to $299M.

Based on Nepsis Inc's 13F filing for Q4 2022, filed 25 Jan 2023.